Notice to Customers. 7.1 GEN-PROBE shall, by means of a label statement applied to each Licensed Kit distributed to a third party, state positively that the Kit comes with only limited field-of-use rights under PHRI Patent Rights, and identifies that field of use, consistent with the terms of the limited grant hereunder, GEN-PROBE shall propose language for this label statement for PHRI’s approval, in view of PHRI’s need to protect its intellectual property rights, approval not to be withheld unreasonably. 7.2 GEN-PROBE shall use the same or a similar PHRI-approved statement in promotional literature for Licensed Kits and Licensed Assays.
Appears in 3 contracts
Samples: License Agreement (Roka BioScience, Inc.), License Agreement (Roka BioScience, Inc.), License Agreement (Roka BioScience, Inc.)
Notice to Customers. 7.1 GEN-PROBE shall, by means of a label statement applied to each Licensed licensed Kit distributed to a third party, state positively that the Kit comes with only limited field-of-use rights under PHRI Patent Rights, and identifies that field of use, consistent with the terms of the limited grant hereunder, . GEN-PROBE shall propose language for this label statement for PHRI’s 's approval, in view of PHRI’s 's need to protect its intellectual property rights, approval not to be withheld unreasonably.
7.2 GEN-PROBE shall use the same or a similar PHRI-approved statement in promotional literature for Licensed licensed Kits and Licensed licensed Assays.
Appears in 1 contract
Samples: License Agreement (Gen Probe Inc)